Related Experiment Video
Updated: Jun 29, 2026
A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring
Published on: November 29, 2024
Scars: a review of emerging and currently available therapies
Richard G Reish1, Elof Eriksson
1Boston, Mass. From the Division of Plastic Surgery, Brigham and Women's Hospital, and Harvard Medical School.
Background:
With the investigation and potential introduction of several novel scar-reducing therapies to the market within the next several years, it is germane to review both the pathophysiology of scarring and the safety and efficacy of currently available and emerging therapeutic agents.
Methods:
An extensive review of the English-language literature was conducted using the MEDLINE database.
Results:
A comprehensive review of the pathophysiology of scarring and scar management, including both emerging and currently available therapies, was completed. Current clinical studies are limited by small sample sizes, lack of well-designed controls, and lack of standardized scar outcome measurement parameters.
Conclusions:
A prominent challenge in the study of scar management is the paucity of well-designed, large, randomized, controlled studies examining existing scar-reducing techniques. The greatest improvement in scar-reducing protocols likely entails a polytherapeutic strategy for management. Further investigation into the role of inflammation in scarring is paramount to the development of improved scar-reducing agents. There is a need for large controlled trials using a polytherapeutic strategy that combines existing and novel agents to provide a standardized evidence-based evaluation of efficacy.
Insights
Emerging scar treatments require a review of how scars form and current/new therapies. Future research should focus on inflammation and large trials combining treatments for better scar management.
Area of Science:
- Dermatology
- Wound Healing
- Regenerative Medicine
Background:
- Scar formation is a complex biological process.
- Novel scar-reducing therapies are emerging.
- Understanding pathophysiology is key for effective treatment.
Purpose of the Study:
- Review scar pathophysiology.
- Evaluate current and emerging scar therapies.
- Identify gaps in clinical research.
Main Methods:
- Extensive literature review.
- MEDLINE database search.
- Analysis of English-language studies.
Main Results:
- Scarring pathophysiology and management reviewed.
- Current clinical studies have limitations (small sample size, poor controls, non-standardized outcomes).
- Need for robust clinical evidence.
Conclusions:
- Paucity of well-designed, large, randomized controlled trials.
- Polytherapeutic strategies likely offer greatest improvement.
- Further research on inflammation and combined therapies is crucial for evidence-based scar management.
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:24Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:24Healing II: Complications
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:30Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...